VCRC Longitudinal Protocol for Aortitis

Status Completed

Clinical Trial Summary

The term 'aortitis' refers to inflammation of the aorta. Aortitis is known to occur in a variety of vasculitides and connective tissue diseases, such as giant cell arteritis (GCA), Takayasu arteritis (TAK), rheumatoid arthritis, and spondyloarthropathies, among others. This study will establish a longitudinal cohort for these diseases.

Clinical Trial Description

This study will develop a longitudinal cohort of patients with different types of aortitis to systematically study the natural history, optimal treatments, and outcomes in this group of diseases. This will provide a resource for future studies and for identification of new biomarkers of aortitis for purposes of diagnosis, disease activity measurement, disease damage assessment, determination of disease states, and evaluation of treatment response. ;

Study Design

Related Conditions & MeSH terms

Aortitis

Clinical Trial Details

NCT number	NCT03022331
Study type	Observational
Source	University of Pennsylvania
Contact
Status	Completed
Phase
Start date	December 4, 2017
Completion date	September 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02967068` - VCRC Tissue Repository
Completed	`NCT01795456` - Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis	N/A
Not yet recruiting	`NCT06271018` - TocILizumab in aorTitis in GCA (TILT)